Scientific Opinion on the substantiation of health claims related to policosanols from sugar cane wax and maintenance of normal blood LDL-cholesterol concentrations (ID 1747, 1748, 1864, 1951, 1954, 4693) and maintenance of normal blood HDL-cholesterol concentrations (ID 1747, 1748, 1864, 1951, 1954, 4693) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 6, 2011, Pages

[No Author Info available]

Author keywords

cholesterol; HDL; health claims; LDL; Policosanols; sugar cane wax

Indexed keywords

EID: 84906934440     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2255     Document Type: Article

References (16)

1. Batista J, Stusser R, Saez F and Perez B, 1996. Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study. International Journal of Clinical Pharmacology and Therapeutics, 34, 134–137.
2. Berthold HK, Unverdorben S, Degenhardt R, Bulitta M and Gouni-Berthold I, 2006. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA, 295, 2262–2269.
3. Canetti MM, Moreira M, Más R, Illnait J, Fernández L and Fernández JC, 1997. Effects of policosanol on primary hypercholesterolemia: a 3-year open-extension follow-up. Current Therapeutic Research, 58, 868–875.
4. Castaño G, Canetti M, Moreira M, Tula L, Más R, Illnait J, Fernández L, Fernández JC and Díaz E, 1995. Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: a 12-month study. Current Therapeutic Research, 56, 819–828.
5. Castaño G, Mas R, Arruzazabala ML, Noa M, Illnait J, Fernandez JC, Molina V and Menendez A, 1999. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. International Journal of Clinical Pharmacology Research, 19, 105–116.
6. Castaño G, Mas R, Fernandez JC, Illnait J, Fernandez L and Alvarez E, 2001. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 56, M186–192.
7. Castaño G, Mas R, Fernandez L, Illnait J, Mendoza S, Gamez R, Fernandez J and Mesa M, 2005. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study. Drugs Under Experimental and Clinical Research, 31 Suppl, 31–44.
8. Chen JT, Wesley R, Shamburek RD, Pucino F and Csako G, 2005. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy, 25, 171–183.
9. Crespo N, Illnait J, Mas R, Fernandez L, Fernandez J and Castaño G, 1999. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. International Journal of Clinical Pharmacology Research, 19, 117–127.
10. Francini-Pesenti F, Beltramolli D, Dall'acqua S and Brocadello F, 2008a. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia. Phytotherapy Research, 22, 318–322.
11. Francini-Pesenti F, Brocadello F, Beltramolli D, Nardi M and Caregaro L, 2008b. Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study. Complementary Therapies in Medicine, 16, 61–65.
12. Hernández F, Illnait J, Más R, Castaño G, Fernández L, González M, Cordovi N and Fernández JC, 1992. Effect of policosanol on serum lipids and lipoproteins in healthy volunteers. Current Therapeutic Research, 51, 568–575.
13. Kassis AN and Jones PJ, 2006. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons. American Journal of Clinical Nutrition, 84, 1003–1008.
14. Kassis AN and Jones PJ, 2008. Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial. Lipids in Health and Disease, 7, 17.
15. Natural Medicines Comprehensive Database, 2006. Policosanol. Available from: www.naturaldatabase.com
16. Pons P, Rodriguez M, Robaina C, Illnait J, Mas R, Fernandez L and Fernandez JC, 1994. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment. International Journal of Clinical Pharmacology Research, 14, 27–33.